Global Access Diagnostics (GADx)

Global Access Diagnostics (GADx) is a leading developer of lateral flow and rapid diagnostic technologies, products and services, offering a full suite of services from concept to validation to manufacturing at flexible volumes. Bringing skills together for real impact, we work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care. GADx has labs and a high volume manufacturing facility in Bedfordshire, UK, as well as labs in Maine, USA. GADx was formed by the acquisition of two companies, Mologic and Global Access Diagnostics, by a consortium of social impact investors called Global Access Health. As part of this transition, GADx became a social enterprise, dedicating its profits and mission to improving the health and wellbeing of underserved populations around the world.